Vaccinia virus mutants containing the major genomic deletions of MVA

Details for Australian Patent Application No. 2011209175 (hide)

Owner Bavarian Nordic A/S

Inventors Hausmann, Juergen; Meisinger-Henschel, Christine; Suter, Mark

Agent Pizzeys

Pub. Number AU-A-2011209175

PCT Pub. Number WO2011/092029

Priority 61/298,942 28.01.10 US; 10007063.0 08.07.10 EP

Filing date 28 January 2011

Wipo publication date 4 August 2011

International Classifications

C12N 7/00 Viruses, e.g. bacteriophages

C12N 7/02 Viruses, e.g. bacteriophages - Recovery or purification

A61K 39/275 Medicinal preparations containing antigens or antibodies - Poxviridae, e.g. avipoxvirus

C12N 15/863 Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/092029 Priority application(s): WO2011/092029

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011209200-A plant for the continuous manufacture of an expandable plastic granulate as well as method for producing it

2011209158-Arrangement and method for optimizing the operation of a supply network